Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lepri

Showing results (781-790 of 959) with videos related to

Pageof 96
Sort By:
Microorganisms|July 2, 2021
Oral <i>Lactobacillus</i> Species in Systemic SclerosisDaniela Melchiorre, Maria Teresa Ceccherini, Eloisa Romano, et al.
Genes|March 29, 2023
The Expanding Phenotype of ZTTK Syndrome Due to the Heterozygous Variant of <i>SON</i> Gene Focusing on Liver Involvement: Patient Report and Literature ReviewAndrea Pietrobattista, Luca Della Volpe, Paola Francalanci, et al.
Head & Face Medicine|February 28, 2024
Exploring the association between PITX2, third molars agenesis and sella turcica morphology : PITX2, third molars agenesis and sella turcica morphologyErika Calvano Küchler, Jordanna de Melo Teixeira do Brasil, Isabela Ribeiro Madalena, et al.
Rheumatology and Immunology Research|December 5, 2022
The Emerging Challenge of Pain in Systemic Sclerosis: Similarity to the Pain Experience Reported by Sjőgren's Syndrome PatientsRossella De Luca, Marco Maresca, Martina Orlandi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 6, 2023
Cellular and molecular antiproliferative effects in 2D monolayer and 3D-cultivated HT-29 cells treated with zerumboneNayane de Oliveira Silva, Luan Vitor Alves de Lima, Liana Martins de Oliveira, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. StudyRita Murri, Alessandro Cozzi Lepri, Andrew N Phillips, et al.
Archives of Disease in Childhood|October 5, 2014
Kabuki syndrome: clinical and molecular diagnosis in the first year of lifeMaria Lisa Dentici, Alessandra Di Pede, Francesca Romana Lepri, et al.
The Journal of Antimicrobial Chemotherapy|February 24, 2026
Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomesLaura Pezzati, Federico Conti, William Gennari, et al.
European Journal of Human Genetics : EJHG|June 21, 2012
A variant in the carboxyl-terminus of connexin 40 alters GAP junctions and increases risk for tetralogy of FallotValentina Guida, Rosangela Ferese, Marcella Rocchetti, et al.
Frontiers in Immunology|April 7, 2022
Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and SurvivalLara Gibellini, Sara De Biasi, Marianna Meschiari, et al.
Pageof 96

Showing results (781-790 of 959) with videos related to

Sort By:
Pageof 96
Microorganisms|July 2, 2021
Oral <i>Lactobacillus</i> Species in Systemic SclerosisDaniela Melchiorre, Maria Teresa Ceccherini, Eloisa Romano, et al.
Genes|March 29, 2023
The Expanding Phenotype of ZTTK Syndrome Due to the Heterozygous Variant of <i>SON</i> Gene Focusing on Liver Involvement: Patient Report and Literature ReviewAndrea Pietrobattista, Luca Della Volpe, Paola Francalanci, et al.
Head & Face Medicine|February 28, 2024
Exploring the association between PITX2, third molars agenesis and sella turcica morphology : PITX2, third molars agenesis and sella turcica morphologyErika Calvano Küchler, Jordanna de Melo Teixeira do Brasil, Isabela Ribeiro Madalena, et al.
Rheumatology and Immunology Research|December 5, 2022
The Emerging Challenge of Pain in Systemic Sclerosis: Similarity to the Pain Experience Reported by Sjőgren's Syndrome PatientsRossella De Luca, Marco Maresca, Martina Orlandi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 6, 2023
Cellular and molecular antiproliferative effects in 2D monolayer and 3D-cultivated HT-29 cells treated with zerumboneNayane de Oliveira Silva, Luan Vitor Alves de Lima, Liana Martins de Oliveira, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. StudyRita Murri, Alessandro Cozzi Lepri, Andrew N Phillips, et al.
Archives of Disease in Childhood|October 5, 2014
Kabuki syndrome: clinical and molecular diagnosis in the first year of lifeMaria Lisa Dentici, Alessandra Di Pede, Francesca Romana Lepri, et al.
The Journal of Antimicrobial Chemotherapy|February 24, 2026
Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomesLaura Pezzati, Federico Conti, William Gennari, et al.
European Journal of Human Genetics : EJHG|June 21, 2012
A variant in the carboxyl-terminus of connexin 40 alters GAP junctions and increases risk for tetralogy of FallotValentina Guida, Rosangela Ferese, Marcella Rocchetti, et al.
Frontiers in Immunology|April 7, 2022
Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and SurvivalLara Gibellini, Sara De Biasi, Marianna Meschiari, et al.
Pageof 96